BELGIUM 27th !!! 1) HTA DE GRADE 3 = TOUJOURS RISQUE > ELEVE 4 - - PowerPoint PPT Presentation

belgium 27th 1 hta de grade 3 toujours risque gt eleve
SMART_READER_LITE
LIVE PREVIEW

BELGIUM 27th !!! 1) HTA DE GRADE 3 = TOUJOURS RISQUE > ELEVE 4 - - PowerPoint PPT Presentation

BELGIUM 27th !!! 1) HTA DE GRADE 3 = TOUJOURS RISQUE > ELEVE 4 3 2) PREVENTION SECONDAIRE ou DIABETE + ATTEINTE ORGANE CIBLE/FACTEUR DE RISQUE = RISQUE ELEVE PEU IMPORTE LA PA 3) Si PAS >140 et/ou 90 mmHg et >3 facteurs de


slide-1
SLIDE 1
slide-2
SLIDE 2

BELGIUM 27th !!!

slide-3
SLIDE 3
slide-4
SLIDE 4
slide-5
SLIDE 5
slide-6
SLIDE 6
slide-7
SLIDE 7
slide-8
SLIDE 8
slide-9
SLIDE 9
slide-10
SLIDE 10

1) HTA DE GRADE 3 = TOUJOURS RISQUE > ELEVE

slide-11
SLIDE 11

2) PREVENTION SECONDAIRE ou DIABETE + ATTEINTE ‘ORGANE CIBLE’/FACTEUR DE RISQUE

= RISQUE ELEVE PEU IMPORTE LA PA

4 3

slide-12
SLIDE 12

3) Si PAS >140 et/ou 90 mmHg et

  • >3 facteurs de risque CV
  • ou atteinte ‘organe cible’
  • ou diabète

= RISQUE ELEVE

slide-13
SLIDE 13
slide-14
SLIDE 14
slide-15
SLIDE 15
slide-16
SLIDE 16
slide-17
SLIDE 17
slide-18
SLIDE 18
slide-19
SLIDE 19
slide-20
SLIDE 20
slide-21
SLIDE 21
slide-22
SLIDE 22
slide-23
SLIDE 23
slide-24
SLIDE 24

LI LIFE E EXPECTANCY A AT 60 Y YRS I IN 2012

slide-25
SLIDE 25
slide-26
SLIDE 26
slide-27
SLIDE 27

Ph van de Borne, L Missault, A Persu, W Van Mieghem for the COME STAI INVESTIGATORS

slide-28
SLIDE 28

Param eters

> 2

m edications

1

m edication m edication

Systolic BP (m m Hg)

139±19 139±18 143±21*

Diastolic BP (m m Hg)

8 0 ±11 8 1±11 8 3±13*

Age (years)

68 ±12 62±13 55±15*

Heart rate (bpm )

72±10 73±9 75±10 *

Body m ass index (kg/ m ² )

29.0 ±5.8 27.2±5.0 26.7±5.2*

S: systolic; D: diastolic; BP: Blood pressure; bpm: beat per minute; * p<0.0001

RESULTS (2): Nr of medications reported in n:7961 patients (0 vs. 1 vs. 2 or more drugs)

slide-29
SLIDE 29

Less intense treatm ent in the elderly :

Among 495 patients aged ≥80 years, and SBP> 140 mmHg, therapy was intensified: in 57% when SBP > 160 mmHg (n=130) in 17% when 140 <SBP<159 mmHg* (n=365)

*p Chi² <0.0001

slide-30
SLIDE 30
slide-31
SLIDE 31
slide-32
SLIDE 32
slide-33
SLIDE 33
slide-34
SLIDE 34
slide-35
SLIDE 35
slide-36
SLIDE 36
slide-37
SLIDE 37
slide-38
SLIDE 38
slide-39
SLIDE 39

Blood pressure in m m Hg ESH/ ESC 20 13[3] ASH/ ISH 20 14 [4] Go A. et al. AHA/ ACC/ CDC 20 13 [5] 20 14 Hypertension guidelines, US “JNC 8 ” [6] Definition of Hypertension ≥140/90 ≥140/90 ≥140/90 Not addressed Drug therapy in low risk patients after non- pharm acologic treatm ent ≥140/90 ≥140/90 ≥140/90 < 60 y. ≥140/90 ≥ 60 y. ≥150/90 Beta-blockers as first line drug Yes No (Step 4) No (Step 3) No (Step 4) Diuretic thiazides chlorthalidone, indapam ide thiazides chlorthalidone indapam ide thiazides thiazides chlorthalidone, indapam ide Initiate drug therapy with two drugs If m arkedly elevated BP ≥160/100 ≥160/100 ≥160/100 Blood pressure targets <140 / 90 Elderly < 8 0 y. SBP 140 -150 SBP <140 in fit patients Elderly ≥ 80 y. SBP 140 -150 <140 / 90 ≥ 80 y. < 150 / 90 <140 / 90 Lower targets m ay be appropriate in som e patients, including the elderly < 60 y. <140 / 90 ≥ 60 y. <150/90 Blood Pressure target in patients with diabetes m ellitus < 140 / 8 5 <140 / 90 <140 / 90 Lower targets m ay be considered <140 / 90

slide-40
SLIDE 40